Exagen Inc. XGN Deferred Tax Liabilities, Right Of Use Assets
Deferred Tax Liabilities, Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept exdx:DeferredTaxLiabilitiesRightOfUseAssets.
The official record: Exagen Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s deferred tax liabilities, right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s deferred tax liabilities, right of use assets?
- Exagen Inc. (XGN) reported deferred tax liabilities, right of use assets of $1.04M in Q4 2025.
- How has Exagen Inc.'s deferred tax liabilities, right of use assets changed year-over-year?
- Exagen Inc.'s deferred tax liabilities, right of use assets increased by 75.5% year-over-year, from $592K to $1.04M.
- What does deferred tax liabilities, right of use assets mean?
- This metric captures the deferred tax liability arising from the temporary differences between the book value and tax basis of right-of-use assets recognized under lease accounting standards. It represents the future tax consequences of the company's leasing arrangements as the asset is amortized over the lease term. This figure is essential for assessing the impact of lease obligations on the company's overall tax profile and future cash outflows.